Digital Spatial Profiling
Prosigna® Breast Cancer Prognostic Gene Signature Assay
to Move Forward
Rapid IO Signature Development
IO 360™ GX Panel
Faster than qPCR. Simpler than NGS.
Expertly Curated. Ready to Use.
nCounter® Analysis Technology
More insights from
The nForm blog provides expert opinions on the latest hot topics in research from Neuroscience to spatial profiling and beyond!
Hear from the Experts
Register for one of our on-demand webinars to learn how customers are using nCounter Technology and also learn about new products in development.
on actionable answers
nFORM BLOG- Autoimmunity
Chief Medical Officer, Alessandra Cesano MD, PhD, discusses her perspective on applying lessons learned from immuno-oncology to the field of autoimmunity research.
June 14, 2018
Take on the challenges of Autoimmunity research with the nCounter® Analysis System - aired July 18, 2018 - 9:00 a.m. (PST)
Kirsteen Maclean, PhD, Principal Field Application Scientist, NanoString
In this webinar, we discuss examples of leading research in the field of Autoimmunity that have utilized the nCounter® Analysis System to address important challenges including the development of gene signatures for early diagnosis, responder-non-responder profiling and treatment-induced autoimmunity.
Morphology-Driven, High-Plex Spatial Analysis of Immune Protein Expression in Lung Cancer - aired June 7, 2018 - 9:30am PST
David Rimm, MD, PhD, Yale University and Doug Hinerfeld, PhD, NanoString
Digital Spatial Profiling (DSP) Technology has the potential to overcome traditional IHC and QIF challenges with oligo-barcoded antibodies and digital readouts for high multi-plexing capability of 800+ targets. This webinar presents data from testing DSP against QIF to evaluate technical performance and how DSP was utilized to identify potential prognostic signatures in lung cancers treated with an immune checkpoint inhibitor.
Cost Effective, Robust Digital Gene Expression Profiling with nCounter® PlexSet™ Reagents - aired May 10 2018 - 10:30 a.m. (PST)
Chris Merritt, PhD, NanoString
Cell line screening studies require highly efficient protocols for studying many samples in parallel. We have developed a lyse-and-go protocol for digital gene expression profiling of up to 96-samples by 96-genes in parallel. This protocol is based on nCounter PlexSet Reagents which enable multiplexing of samples and gene targets.